FR2929518B1 - Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane - Google Patents

Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Info

Publication number
FR2929518B1
FR2929518B1 FR0852277A FR0852277A FR2929518B1 FR 2929518 B1 FR2929518 B1 FR 2929518B1 FR 0852277 A FR0852277 A FR 0852277A FR 0852277 A FR0852277 A FR 0852277A FR 2929518 B1 FR2929518 B1 FR 2929518B1
Authority
FR
France
Prior art keywords
appendix
proteins
treatment
skin aging
cosmetic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0852277A
Other languages
English (en)
Other versions
FR2929518A1 (fr
Inventor
Dominique Bernard
Lucie Simonetti
Isabelle Castiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0852277A priority Critical patent/FR2929518B1/fr
Publication of FR2929518A1 publication Critical patent/FR2929518A1/fr
Application granted granted Critical
Publication of FR2929518B1 publication Critical patent/FR2929518B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0852277A 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane Expired - Fee Related FR2929518B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0852277A FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852277A FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Publications (2)

Publication Number Publication Date
FR2929518A1 FR2929518A1 (fr) 2009-10-09
FR2929518B1 true FR2929518B1 (fr) 2013-06-28

Family

ID=39864833

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0852277A Expired - Fee Related FR2929518B1 (fr) 2008-04-04 2008-04-04 Utilisation cosmetique de proteines de type annexine ii pour le traitement du vieillissement cutane

Country Status (1)

Country Link
FR (1) FR2929518B1 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856315T2 (de) * 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
DE10100121A1 (de) * 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
US7547454B2 (en) * 2002-11-07 2009-06-16 Shyam K Gupta Hydroxy acid complexes for antiaging and skin renovation
WO2004080424A2 (fr) * 2003-03-13 2004-09-23 The Brigham And Women's Hospital, Inc. Methodes et compositions permettant de detecter une excroissance de neurite
US20050152862A1 (en) * 2003-10-29 2005-07-14 L'oreal Cosmetic peeling method
EP1776087B1 (fr) * 2004-08-13 2014-06-25 Henkel AG & Co. KGaA Compositions cosmetiques et dermatologiques a base de (2-hydroxyethyl)uree
FR2878438B1 (fr) * 2004-11-26 2009-07-03 Oreal Composition cosmetique comprenant un agent tenseur et une hydroxyalkyl uree
KR101165848B1 (ko) * 2005-08-18 2012-07-13 (주)아모레퍼시픽 효소 및 아미노산을 함유하는 피부 화장료 조성물
US7972788B2 (en) * 2005-08-23 2011-07-05 Fancl Corporation Skin aging marker and technique for use thereof
FR2898046A1 (fr) * 2006-03-03 2007-09-07 Oreal Emulsion contenant de hydroxyacides
JP4675806B2 (ja) * 2006-03-16 2011-04-27 日本メナード化粧品株式会社 アネキシン活性化剤
FR2903303B1 (fr) * 2006-07-07 2011-12-09 Labo Dermatologiques D'uriage Compositions dermatologiques et/ou cosmetologiques destinees a lutter contre le vieillissement cutane

Also Published As

Publication number Publication date
FR2929518A1 (fr) 2009-10-09

Similar Documents

Publication Publication Date Title
FR2925312B1 (fr) Utilisation cosmetique de proteines de type desmogleine i
EP2391208A4 (fr) Compositions pour le traitement des ongles et de la peau
EP2606131A4 (fr) Utilisation de protéines de la famille 61 des glycoside hydrolases dans le traitement de la cellulose
FR2924946B1 (fr) Utilisation cosmetique de proteines de type ceramidase acide
BRPI0912402A2 (pt) processos e kit de tratamento dos cabelos
IL259547B (en) Isolated protein and preparations containing it for use in the treatment of disorders caused by il-1
EP2938626A4 (fr) Hydrogels peptidiques ultracourts auto-assemblés pour cicatrisation de plaies, soins de la peau et applications cosmétiques
EP2461765A4 (fr) Rajeunissement cosmétique de la peau
EP2291839A4 (fr) Applicateur acoustique pour formulations cutanées
EP2465446A4 (fr) Instrument de traitement pour endoscope
PL2282675T3 (pl) System do zabiegu kosmetycznego i obrazowania
EP2306836A4 (fr) Modulateurs de l expression de la protéine bmi-1
EP2125002A4 (fr) Traitement du cancer de la peau
EP2654745A4 (fr) Composition pour le traitement d'états pathologiques de la peau
EP2630949A4 (fr) Composition cosmétique, produit cosmétique pour les cheveux et produit cosmétique de traitement des cheveux
EP2502939A4 (fr) Protéine non naturelle de type collagène et son utilisation
FR2974297B1 (fr) Nouvelle utilisation cosmetique ou therapeutique du tripeptide ghk
FR2917629B1 (fr) Utilisation cosmetique de proteines de type apolipoproteine d
EP2387418A4 (fr) Traitement de la douleur
EP2544692A4 (fr) Utilisation de la tigécycline pour le traitement du cancer
EP2209458A4 (fr) Compositions de traitement de la peau
EP2702992A4 (fr) Utilisation de mélatonine pour le traitement et/ou la prévention de la mucosite
FR2920309B1 (fr) Utilisation de travoprost pour traiter la chute des cheveux
EP2934380A4 (fr) Hydrogels contenant de la fibroïne destinés au traitement du tissu pelvien
EP2861239A4 (fr) Compositions topiques pour le traitement de maladies inflammatoires chroniques de la peau

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20161230